EUVIMEDEUVIMED entdecken
Crossref

Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM

Kateřina Michnová

Transfuze a hematologie dnes · 2023

DOI: 10.48095/cctahd2023207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfuze a hematologie dnes, 2023. Verfasst von Kateřina Michnová.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Michnová, K. (2023). Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM. Transfuze a hematologie dnes. https://doi.org/10.48095/cctahd2023207

Vancouver

Michnová K. Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM. Transfuze a hematologie dnes. 2023. doi:10.48095/cctahd2023207

BibTeX
@article{Michnov2023,
  author = {Michnová, Kateřina},
  title = {Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM},
  journal = {Transfuze a hematologie dnes},
  year = {2023},
  doi = {10.48095/cctahd2023207}
}
Kostenlos starten →